Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Andra Ibrahim Duncan, MD, is a staff anesthesiologist in the Department of Cardiothoracic Anesthesiology and Critical Care Medicine at Cleveland Clinic. She is board-certified in Anesthesiology and Critical Care Medicine. Dr. Duncan specializes in cardiothoracic anesthesiology and critical care.
A native of Minnesota, Dr. Duncan received her medical degree from the University of Minnesota School of Medicine. While a student, she received the Lange Medical Student Award. She did her clinical training with an internship in internal medicine at University Hospital in Boston followed by a residency in anesthesiology at Brigham & Women’s Hospital in Boston. She completed fellowships in Critical Care Medicine from Massachusetts General Hospital and in cardiac anesthesia from Children’s Hospital in Boston. Her undergraduate work was in music at Gustavus Adolphus College in Minnesota. She was a Visiting Scholar in music at Mozarteum in Salzburg.
Prior to her appointment to Cleveland Clinic in 2001 as a staff anesthesiologist, Dr. Duncan was appointed as an assistant professor in the Department of Anesthesiology at Boston University School of Medicine and served as an attending anesthesiologist at Boston University Medical Center and as the Director of the Post-Anesthesia Care Unit. Dr. Duncan also served as Attending Anesthesiologist and Assistant Professor in the Department of Anesthesiology at the University of Washington Medical Center in Washington.
Dr. Duncan is the recipient of the John J. Downes Research Award. Her peer-reviewed research efforts have focused on the influence of gender, oral hypoglycemic agents, and left ventricular remodeling on outcomes following cardiac surgery. Dr. Duncan is currently the principal investigator of a large study investigating the benefits of glucose control in cardiac surgical patients.
She has published articles and abstracts on her specialty interests, research findings and clinical experience in leading peer-reviewed medical journals including the Journal of Thoracic and Cardiovascular Surgery, the Annals of Thoracic Surgery, and Anesthesiology, to name a few. She is the co-author of a chapter on “Volatile, Local and Intravenous Anesthetics” in a medical textbook and is the sole author of a chapter on the long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support.
Dr. Duncan is a member of the American Society of Anesthesiologists, the Society of Cardiovascular Anesthesiologists, the International Anesthesia Research Society, the
American Society of Critical Care Anesthesiologists, and the Massachusetts Medical Society.
cardiothoracic anesthesiology, clinical research, critical care medicine, fellow and resident education, intraoperative TEE, intraoperative transesophageal echocardiography, resident teaching
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/6/2016, Dr. Duncan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.